Literature DB >> 3122506

Human cystatins in normal and diseased tissues--a review.

M Järvinen1, A Rinne, V K Hopsu-Havu.   

Abstract

Immunohistochemica and quantitative immunochemical methods were used to demonstrate the presence of two cysteine proteinase inhibitors, cystatins A and B, in normal and diseased tissues. Cystatin A is expressed in squamous epithelia, neutrophil granulocytes, and dendritic reticulum cells of the lymphatic tissues. Its concentration is increased in inflammatory skin diseases and decreases after the malignization of squamous epithelia. Cystatin B is seen in wet squamous epithelia, and in the cells of monocyte-macrophage series, where its concentration varies depending on the activation state of the cells. In the malignant keratinocytes cystatin B follows the behaviour of cystatin A.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3122506     DOI: 10.1016/S0065-1281(87)80043-0

Source DB:  PubMed          Journal:  Acta Histochem        ISSN: 0065-1281            Impact factor:   2.479


  10 in total

1.  Biological and prognostic role of acid cysteine proteinase inhibitor (ACPI, cystatin A) in non-small-cell lung cancer.

Authors:  T Leinonen; R Pirinen; J Böhm; R Johansson; A Rinne; E Weber; V-M Kosma
Journal:  J Clin Pathol       Date:  2006-06-21       Impact factor: 3.411

2.  Functional expression of recombinant human stefin A in mammalian and bacterial cells.

Authors:  Catharine C Calkins; Julie Dosescu; Nancy A Day; Wei-Ping Ren; Rafael Fridman; Bonnie F Sloane; Kamiar Moin
Journal:  Protein Expr Purif       Date:  2006-12-09       Impact factor: 1.650

3.  Expression of cysteine protease inhibitors in human gliomas and meningiomas.

Authors:  M Sivaparvathi; I McCutcheon; R Sawaya; G L Nicolson; J S Rao
Journal:  Clin Exp Metastasis       Date:  1996-09       Impact factor: 5.150

4.  Targeted quantitative mass spectrometric immunoassay for human protein variants.

Authors:  Olgica Trenchevska; Dobrin Nedelkov
Journal:  Proteome Sci       Date:  2011-04-08       Impact factor: 2.480

5.  Deciphering c-MYC-regulated genes in two distinct tissues.

Authors:  Samuel C Robson; Lesley Ward; Helen Brown; Heather Turner; Ewan Hunter; Stella Pelengaris; Michael Khan
Journal:  BMC Genomics       Date:  2011-09-30       Impact factor: 3.969

Review 6.  Cysteine cathepsins as regulators of the cytotoxicity of NK and T cells.

Authors:  Milica Perišić Nanut; Jerica Sabotič; Anahid Jewett; Janko Kos
Journal:  Front Immunol       Date:  2014-12-02       Impact factor: 7.561

7.  The association of plasma cystatin C proteoforms with diabetic chronic kidney disease.

Authors:  Hussein N Yassine; Olgica Trenchevska; Zhiwei Dong; Yara Bashawri; Juraj Koska; Peter D Reaven; Randall W Nelson; Dobrin Nedelkov
Journal:  Proteome Sci       Date:  2016-03-25       Impact factor: 2.480

8.  Vernix caseosa as a multi-component defence system based on polypeptides, lipids and their interactions.

Authors:  M Tollin; G Bergsson; Y Kai-Larsen; J Lengqvist; J Sjövall; W Griffiths; G V Skúladóttir; A Haraldsson; H Jörnvall; G H Gudmundsson; B Agerberth
Journal:  Cell Mol Life Sci       Date:  2005-10       Impact factor: 9.261

9.  Loss of Grainy head-like 1 is associated with disruption of the epidermal barrier and squamous cell carcinoma of the skin.

Authors:  Michal Mlacki; Charbel Darido; Stephen M Jane; Tomasz Wilanowski
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

10.  Clinical features of cystatin A expression in patients with pancreatic ductal adenocarcinoma.

Authors:  Takuya Komura; Hisashi Takabatake; Kenichi Harada; Masatoshi Yamato; Masaki Miyazawa; Keiko Yoshida; Masao Honda; Takashi Wada; Hirohisa Kitagawa; Tetsuo Ohta; Shuichi Kaneko; Yoshio Sakai
Journal:  Cancer Sci       Date:  2017-10-08       Impact factor: 6.716

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.